Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


MaxDiscovery™ Human IL-29 ELISA Test Kit

Product Description
The MaxDiscovery™ Human IL-29 ELISA Test Kit is designed for quantitative determination of the concentration of human IL-29 in serum, plasma, and cell culture supernatant. Human interleukin 29 (IL-29) is a cytokine distantly related to type I interferons and the IL-10 family. IL-29, interleukin 28A (IL-28A) and interleukin 28B (IL-28B), known as IFN?1, ?2, and ?3, are three closely related cytokine genes that form a cytokine gene cluster on chromosome 19. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor beta (IL-10Rß) and interleukin 28 receptor alpha (IL-28Ra). IFN?s are a novel family of interferons which mediate the induction of antiviral protection in a wide variety of cells. IFN?s share with type I IFNs an intracellular signaling pathway that drives the expression of a common set of IFN stimulated genes. IFN?s induce multiple biological activities, including the upregulation of class I MHC gene product expression to levels comparable to those induced by IFNa. Consistent with a role in antiviral protection, the mRNA expression of IFN? is detectable in cells infected with various viruses. Furthermore, monocytederived dendritic cells (important producers of IFNa) express IFN?1mRNA in response to treatment with dsRNA. TLR3 and TLR4 ligands induce IFNa, IFNß, IL-28, and IL-29 gene expression in macrophages. This is dependent upon IFNa. IFN? mediates its antiviral protection through a class II cytokine receptor complex distinct from that of type I IFNs. This is comprised of two essential receptor proteins, CRF212/IFN?R1, which is unique to IFN?, and CFR24/IL10R2, which is shared with IL10, IL22, and IL26 receptors. Whereas, the two chains of the type I IFN receptor (IFNAR1 and IFNAR2) and IL10R2 are ubiquitously expressed, IFN?R1 expression is limited and celltype dependent. IFN?R1 is not expressed by monocytes, but is upregulated during GMCSF/ IL4 induced differentiation of DCs from human monocytes, yielding iDCs which are fully responsive to IFN?. The IFN?s, IL28 and IL29, have recently been reported to prime dendritic cells to induce proliferation of Foxp3 bearing regulatory T cells. IFN? matured DCs express high levels of class I and II MHC gene products, but low levels of costimulatory molecules, and are able to specifically induce IL-2dependent proliferation of CD4+CD25+FOXP3+ T cell population with contact dependent suppressive activity on T cells.
Product MaxDiscovery™ Human IL-29 ELISA Test Kit
Company BIOO Scientific - Product Directory
Price Request a quote
More Information View company product page
Catalog Number 2128-01
Quantity 1 x 96 wells
Company Logo

BIOO Scientific - Product Directory
3913 Todd Lane Suite 312 Austin, TX 78744, USA

Tel: +1 512-707-8993
Fax: +1 512-707-8122
Email: info@biooscientific.com



Scientific News
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!